Insight

Akhil Santhosh

Apr 9, 2025, 02:49

Akhil Santhosh: Toripalimab plus axitinib in patients with stage 4 mucosal melanoma

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“Toripalimab plus axitinib in patients with stage 4 mucosal melanoma: 3-year survival update and biomarker analysis

9pts phase data
Median PFS 7.5m
3 year OS 3%
gene GEP correlates with increased PFS and OS.”

“Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis”

Authors: Siming Li, Xiaowen Wu, Xieqiao Yan, Li Zhou, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Lili Mao, Bin Lian, Xuan Wang, Xue Bai, Jie Dai, Yan Kong, Xiongwen Tang, Hui Feng, Sheng Yao, Keith T Flaherty, Jun Guo, Xinan Sheng

Akhil Santhosh

Akhil Santhosh Bin Lian Bixia Tang cancer Chuanliang Cui Hui Feng Jie Dai Jun Guo Keith T. Flaherty Li Zhou Lili Mao Lu Si OncoDaily Oncology Sheng Yao Siming Li Xiaowen Wu Xieqiao Yan Xinan Sheng Xiongwen Tang Xuan Wang Xue Bai Yan Kong Zhihong Chi

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action